Multiple MicroRNAs Ameliorate Hepatocyte Steatosis and Injury by Suppressing FABP1 Expression
Background/Aims: Liver fatty acid–binding protein (FABP1) is a key regulator of hepatic lipid metabolism. MicroRNAs (miRNAs) are thought to be involved in nonalcoholic fatty liver disease (NAFLD), and the underlying mechanism is largely unclear. We investigated whether miRNAs influence hepatocyte st...
Main Authors: | Yun-li Wu, Yi-Bing Zhu, Rong-dong Huang, Xian-e Peng, Xu Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-12-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/486058 |
Similar Items
-
Alterations in Cytoskeleton and Mitochondria in the Development and Reversal of Steatosis in Human HepatocytesSummary
by: Letao Fan, et al.
Published: (2023-01-01) -
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01) -
Honokiol Improves Liver Steatosis in Ovariectomized Mice
by: Yeon-Hui Jeong, et al.
Published: (2018-01-01) -
Nonalcoholic Fatty Liver Disease and MicroRNAs: A Weighty Consideration
by: Sanjukta Mishra, et al.
Published: (2023-01-01) -
Steatosis influences hepatocytes proliferative potential in chronic hepatitis C patients
by: Andrzej Gabriel, et al.
Published: (2019-01-01)